Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma

Published:2022-01-13 Issue:4 Volume:36 Page:1078-1087
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Waldschmidt Johannes M.,Yee Andrew J.,Vijaykumar Tushara,Pinto Ricardo A.^ORCID,Frede Julia^ORCID,Anand Praveen,Bianchi Giada^ORCID,Guo Guangwu,Potdar Sayalee^ORCID,Seifer Charles,Nair Monica S.,Kokkalis Antonis^ORCID,Kloeber Jake A.^ORCID,Shapiro Samantha,Budano Lillian,Mann Mason,Friedman Robb,Lipe Brea,Campagnaro Erica,O’Donnell Elizabeth K.,Zhang Cheng-Zhong,Laubach Jacob P.^ORCID,Munshi Nikhil C.^ORCID,Richardson Paul G.^ORCID,Anderson Kenneth C.^ORCID,Raje Noopur S.,Knoechel Birgit^ORCID,Lohr Jens G.^ORCID

Funder

Deutsche Forschungsgemeinschaft

International Myeloma Society

U.S. Department of Health & Human Services | NIH | National Cancer Institute

V Foundation for Cancer Research

Anna Fuller Fund

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01492-y.pdf

Reference60 articles.

1. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122–28.

2. Keats JJ, Chesi M, Egan JB, Garbitt VM, Palmer SE, Braggio E, et al. Clonal competition with alternating dominance in multiple myeloma. Blood. 2012;120:1067–76.

3. Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D, et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell. 2014;25:91–101.

4. Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I, et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014;5:2997.

5. Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol. 2005;23:6333–38.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future;Blood Reviews;2024-09

2. Impact of Clonal Heterogeneity in Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-04

3. Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study;Leukemia & Lymphoma;2024-03-03

4. An Investigation into Cell-Free DNA in Different Common Cancers;Molecular Biotechnology;2023-12-10

5. TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy;Blood Advances;2023-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3